Intelligence · Clinical Pipeline
United Therapeutics Europe Pipeline
All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.
- Programs
- 199
Quick answer
United Therapeutics Europe has 199 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
radiation therapy
United Therapeutics Europe Ltd
Bladder Cancer
1 trial -
recombinant interferon alfa
United Therapeutics Europe Ltd
Melanoma (Skin)
1 trial -
selenase (selenium)
United Therapeutics Europe Ltd
Osteoporosis
1 trial -
trastuzumab
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
treprostinil sodium
United Therapeutics Europe Ltd
Liver Transplant
1 trial -
vitamin A supplementation (15,000 ug retinol equivalents or 50,000 IU)
United Therapeutics Europe Ltd
Mortality Through Six Months of Age
1 trial -
zinc sulphate dietary supplement
United Therapeutics Europe Ltd
Nutrition
1 trial
Frequently asked questions
How many pipeline programs does United Therapeutics Europe have?
199 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs